Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research and Treatment
Published in: Breast Cancer Research and Treatment 2/2006

01-09-2006 | Preclinical study

Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer

Authors: Sebastian F. Schoppmann, Alexandra Fenzl, Monika Schindl, Thomas Bachleitner-Hofmann, Katalin Nagy, Michael Gnant, Reinhard Horvat, Raimund Jakesz, Peter Birner

Published in: Breast Cancer Research and Treatment | Issue 2/2006

Login to get access
Metadata
Title
Hypoxia inducible factor-1α correlates with VEGF-C expression and lymphangiogenesis in breast cancer
Authors
Sebastian F. Schoppmann
Alexandra Fenzl
Monika Schindl
Thomas Bachleitner-Hofmann
Katalin Nagy
Michael Gnant
Reinhard Horvat
Raimund Jakesz
Peter Birner
Publication date
01-09-2006
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 2/2006
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-006-9190-3

Other articles of this Issue 2/2006

Breast Cancer Research and Treatment 2/2006 Go to the issue

Preclinical investigation

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

Epidemiology

Adherence to tamoxifen over the five-year course

Epidemiology

Flame-broiled food, NAT2acetylator phenotype, and breast cancer risk among women with benign breast disease

Preclinical study

LHRH-conjugated Magnetic Iron Oxide Nanoparticles for Detection of Breast Cancer Metastases

Epidemiology

Chronological changes of clinical characteristics in 31,115 new breast cancer patients among Koreans during 1996–2004

Preclinical study

The role of aromatase and 17-β-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits